IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,932,842 | -12.9% | 51,174 | +1.9% | 0.02% | -14.3% |
| Q3 2022 | $2,220,000 | -39.5% | 50,199 | -49.4% | 0.03% | -31.7% |
| Q2 2022 | $3,670,000 | -0.1% | 99,129 | 0.0% | 0.04% | +13.9% |
| Q1 2022 | $3,672,000 | +41.8% | 99,129 | +16.5% | 0.04% | +44.0% |
| Q4 2021 | $2,590,000 | +102.5% | 85,103 | +123.2% | 0.02% | +92.3% |
| Q3 2021 | $1,279,000 | -14.7% | 38,132 | +1.4% | 0.01% | -13.3% |
| Q2 2021 | $1,500,000 | -11.2% | 37,600 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $1,690,000 | -20.5% | 37,600 | 0.0% | 0.02% | -21.7% |
| Q4 2020 | $2,126,000 | +19.2% | 37,600 | 0.0% | 0.02% | +9.5% |
| Q3 2020 | $1,784,000 | -19.5% | 37,600 | 0.0% | 0.02% | -19.2% |
| Q2 2020 | $2,217,000 | -38.7% | 37,600 | -50.8% | 0.03% | -40.9% |
| Q1 2020 | $3,616,000 | +53.6% | 76,476 | +96.3% | 0.04% | +91.3% |
| Q4 2019 | $2,354,000 | -7.0% | 38,963 | -7.8% | 0.02% | -11.5% |
| Q3 2019 | $2,531,000 | -5.0% | 42,246 | +1.9% | 0.03% | +8.3% |
| Q2 2019 | $2,664,000 | – | 41,443 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |